References
- Collaborative Normal-Tension Glaucoma Study GroupComparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressuresAm J Ophthalmol199812644874979780093
- Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol199812644985049780094
- Garway-HeathDFCrabbDPBunceCLatanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trialLancet201538599751295130425533656
- SaitoYSaekiTSugiyamaKLong-term effects of isopropyl unoprostone monotherapy on intraocular pressure and visual field for normal tension glaucoma and primary open angle glaucoma patientsNippon Ganka Gakkai Zasshi20061109717722 Japanese17025229
- SaitoMTakanoRShiratoSEffects of latanoprost and unoprostone when used alone or in combination for open-angle glaucomaAm J Ophthalmol2001132448548911589867
- SusannaRJrGiampaniJJrBorgesASVessaniRMJordaoMLA double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertensionOphthalmology2001108225926311158796
- AungTChewPTYipCCA randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertensionAm J Ophthalmol2001131563664211336940
- JampelHDBacharachJSheuWPRandomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressureAm J Ophthalmol2002134686387112470755
- SponselWEParisGTrigoYPenaMComparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucomaAm J Ophthalmol2002134455255912383812
- ThiemeHStumpffFOttleczAPericotCLLambrouGNWiederholtMMechanisms of action of unoprostone on trabecular meshwork contractilityInvest Ophthalmol Vis Sci200142133193320111726622
- CuppolettiJMalinowskaDHTewariKPChakrabartiJUenoRUnoprostone isopropyl and metabolite M1 activate BK channels and prevent ET-1-induced [Ca2+]i increases in human trabecular meshwork and smooth muscleInvest Ophthalmol Vis Sci20125395178518922786902
- TorisCBZhanGCamrasCBIncrease in outflow facility with unoprostone treatment in ocular hypertensive patientsArch Ophthalmol2004122121782178715596580
- KimuraIShinodaKTaninoTOhtakeYMashimaYEffect of topical unoprostone isopropyl on optic nerve head circulation in controls and in normal-tension glaucoma patientsJpn J Ophthalmol200549428729316075327
- SugiyamaTMashimaYYoshiokaYOkuHIkedaTEffect of unoprostone on topographic and blood flow changes in the ischemic optic nerve head of rabbitsArch Ophthalmol2009127445445919365024
- Garway-HeathDFPoinoosawmyDFitzkeFWHitchingsRAMapping the visual field to the optic disc in normal tension glaucoma eyesOphthalmology2000107101809181511013178
- OgawaIImaiKLong-term effects on visual fields of unoprostone for normal-tension glaucomaFolia Ophthalmol Jpn200354571577
- ShiraiHSakumaTSoganoSKitazawaYVisual field change and risk factors for progression of visual field damage in low tension glaucomaNippon Ganka Gakkai zasshi1992963352358 Japanese1580219
- KobayashiHKobayashiKOkinamiSA comparison of intraocular pressure-lowering effect of prostaglandin F2-α analogues, latanoprost, and unoprostone isopropylJ Glaucoma200110648749211740220
- AzumaIMasudaKKitazawaYTakaseMYamauraHDouble-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertensionJpn J Ophthalmol19933745145258145398
- SugiyamaTAzumaIEffect of UF-021 on optic nerve head circulation in rabbitsJpn J Ophthalmol19953921241298538067
- MelamedSNeuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: clinical benefits in the treatment of glaucomaDrugs Exp Clin Res2002282–3637312224379